A patent related to T-ignite technology granted in US

October 13th, 2021 | Press Release

A patent (US20190015490A1 “T cell inducing vaccine containing an inter-epitope sequence that promotes antigen presentation”), which we hold an exclusive non-exclusive license, was granted in the United States. The patent (Patent No. 6558699) has been also granted in Japan.

Back to Press releases

We want to provide you with the most important information and services in the best possible way. In order to do this, we need your consent to use the web analysis tool »Google Analytics« to create and evaluate an anonymous analysis of your visit for statistical purposes. You can change your consent at any time on the data protection page, otherwise it will remain valid for twelve months.